CD1A and neoplasm: This might especially be of interest if besides a tumor specific SLP and αGC, another skin memory epitope is included in the vaccine as additional natural adjuvant, whereby CD14+ cells potentially could locally activate Trm to in their turn activate CD1a+ dDC to carry tumor antigens to the LN for subsequent activation of cytotoxic T-cells.